Not Sure?

Finding the right test doesn’t have to be overwhelming or expensive. To help you, the Meenta marketplace brings together the widest array of diagnostic products and laboratory services combined with world-class scientific expertise and clinical oversight all in one place. If you have questions, we have answers, just ask us!

Olympic and Paralympic Pre-travel to Japan: Lucira All-In-One COVID-19 Test Kit + Physician Oversight

$75.00

The Point of Care Lucira COVID-19 All-In-One Test provides PCR quality molecular accuracy in 30 minutes or less. This test is authorized for use in specific patient care settings, and includes Meenta medical oversight services and a full results report.

Compare
Description

Welcome! If you’re affiliated with the Olympics or Paralympics, please click here for your instructions for getting safely to Tokyo. The Point of Care Lucira COVID-19 All-In-One Test provides PCR quality molecular accuracy in 30 minutes or less. This test includes Meenta medical oversight services and a full results PDF report generated by the Meenta Clinical Team on behalf of the ordering physician.

Key Features

  • FDA/EUA: The first FDA EUA authorized single-use molecular POC test.
  • Accuracy: In clinical evaluation, the Positive Percent Agreement (PPA) was 94.1% and the Negative Percent Agreement (NPA) was 98.0%.
  • Fast Results: Results in as fast as 11 minutes for a positive result and 30 minutes for a negative result.
  • Medical Oversight: This test includes medical oversight and results reporting.

 

If you are not associated with the US Olympic or Paralympic teams, please see the following alternative products:

 

Test Details

The Lucira COVID-19 All-In-One Test Kit is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is authorized for prescription home use with self-collected nasal swab samples in individuals aged 14 and older who are suspected of COVID-19 by their healthcare provider. This test is authorized for use at the Point of Care (POC), in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation, for individuals aged 14 and older, and in individuals aged 13 and under when the specimen is collected by a healthcare provider at the POC. This test utilizes a molecular amplification technology for the detection of SARS-CoV-2 RNA in individuals with known or suspected COVID-19. This product does not include the LUCI Pass software.

Payment Methods
  • Credit Card
  • PO Number

Questions?

Call (888) 204-5303 or email support@meenta.io

More information about COVID-19 can be found on the CDC website and the Meenta blog.